Browse Category

NASDAQ:UUUU News 13 October 2025 - 4 January 2026

Energy Fuels stock jumps nearly 12% as uranium miners rally on Denison Phoenix update

Energy Fuels stock jumps nearly 12% as uranium miners rally on Denison Phoenix update

Energy Fuels Inc shares rose 11.8% to $16.26 in New York trading Friday, with about 8.7 million shares changing hands by early afternoon. Denison Mines gained 11% after saying it was ready to start building its Phoenix uranium mine in Canada, pending regulatory approvals. Cameco and Uranium Energy also advanced. Denison raised its initial capital estimate for Phoenix to $600 million, up 20% from 2023.
Energy Fuels (UUUU) Stock Skyrockets on Rare-Earth Breakthrough & Uranium Boom

Energy Fuels (UUUU) Stock Skyrockets on Rare-Earth Breakthrough & Uranium Boom

Recent News Company Overview and Strategy Energy Fuels’ core operations include the Pinyon Plain high-grade uranium mine and the White Mesa Mill in Utah (pictured). It was founded in 1987 and today is “a Colorado-based player in… critical minerals — think uranium, rare earth element (REE) processing, vanadium production, and heavy mineral sands operations” finimize.com. The company has been the leading U.S. producer of uranium concentrate for several years investors.energyfuels.com, supplying nuclear utilities for carbon-free power. It owns multiple uranium assets (conventional and ISR) and in 2024-25 ramped up Pinyon Plain (AZ) to record grades and output investors.energyfuels.com. Energy Fuels

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop